Dementia Japan 25: 120-128, 2011

The molecular pathology of frontotemporal lobar degeneration

Tetsuaki Arai1,2), Makiko Yamashita3), Masato Hosokawa2), Takashi Nonaka3), Zen Kobayashi2,4), Masato Hasegawa3), Haruhiko Akiyama2), Takashi Asada1)

1)Department of Psychiatry, Graduate School of Comprehensive Human Sciences, University of Tsukuba2)Department of Dementia and Higher Brain Function Tokyo Metropolitan Institute of Medical Science3)Department of Neuropathology and Cell Biology Tokyo Metropolitan Institute of Medical Science

    Frontotemporal lobar degeneration (FTLD) is a clinical syndrome characterized by behavioral and language difficulties, which refers to a clinically, genetically, and neuropathologically heterogeneous group of neurodegenerative disorders.  Familial FTLD has been linked to mutations in several genes:the microtubule-associated protein tau (MAPT), granulin (GRN), valosin-containing protein (VCP) and charged multivescicular body protein 2B (CHMP2B), and genetic locus on chromosome 9p linked to familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.  The associated neuropathology is characterized by selective degeneration of the frontal and temporal lobes with the neuronal and glial inclusions.  The current classification of FTLD neuropathology is based on the major constituent protein of them:tau, TAR DNA-binding protein of 43kD (TDP-43), and fused in sarcoma (FUS).  Abnormal phosphorylation, ubiquitination, and proteolytic cleavage are the common pathologic signature of tau and TDP-43 accumulated in diseased brains.Especially, the band patterns of C-terminal fragments of these accumulated proteins on immunoblotting are associated with the clinical features of FTLD-tau or FTLD-TDP.  Recent findings of TDP-43 and FUS reveal that FTLD and ALS share a common mechanism of neurodegeneration.  This review focuses on the current understanding of the molecular pathology of FTLD, and their relevance to the development of the therapeutics.


Address correspondence to Dr. Tetsuaki Arai, Department of Psychiatry, Graduate School of Comprehensive Human Sciences, University of Tsukuba (1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8575, Japan)